Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples

Accuracy of Fecal Immunochemical Tests for Colorectal Cancer

(2014) Jeffrey K. Lee et al.   ANNALS OF INTERNAL MEDICINE

Multitarget Stool DNA Testing for Colorectal-Cancer Screening

(2014) Thomas F. Imperiale et al.   NEW ENGLAND JOURNAL OF MEDICINE

Plasma Septin9 versus Fecal Immunochemical Testing for Colorectal Cancer Screening: A Prospective Multicenter Study

(2014) David A. Johnson et al.   PLoS One

Association of skirt size and postmenopausal breast cancer risk in older women: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

(2014) E.-O. Fourkala et al.   BMJ Open

A Population-based Comparison of Immunochemical Fecal Occult Blood Tests for Colorectal Cancer Screening

(2013) Thibaut Raginel et al.   GASTROENTEROLOGY

Prospective evaluation of methylatedSEPT9in plasma for detection of asymptomatic colorectal cancer

(2013) Timothy Robert Church et al.   GUT

Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update

(2013) M.J. Duffy et al.   INTERNATIONAL JOURNAL OF CANCER

Comparison of screen-detected and interval colorectal cancers in the Bowel Cancer Screening Programme

(2012) M D Gill et al.   BRITISH JOURNAL OF CANCER

Increased Plasma Levels of the APC-Interacting Protein MAPRE1, LRG1, and IGFBP2 Preceding a Diagnosis of Colorectal Cancer in Women

(2012) J. J. Ladd et al.   Cancer Prevention Research

Colorectal-Cancer Incidence and Mortality with Screening Flexible Sigmoidoscopy

(2012) Robert E. Schoen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of compliance for colorectal cancer screening and surveillance by colonoscopy based on risk

(2011) David P. Taylor et al.   GENETICS IN MEDICINE

Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests

(2011) Richard F A Logan et al.   GUT

Cancer: Missing the mark

(2011) Lizzie Buchen   NATURE

A Combination of Serum Markers for the Early Detection of Colorectal Cancer

(2010) N. Wild et al.   CLINICAL CANCER RESEARCH

Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)

(2010) S. R. Cairns et al.   GUT

Flexible Sigmoidoscopy Screening for Colorectal Cancer: Uptake in a Population-based Pilot Programme

(2010) Kathryn Robb et al.   JOURNAL OF MEDICAL SCREENING

Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial

(2010) Wendy S Atkin et al.   LANCET

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

(2009) Usha Menon et al.   LANCET ONCOLOGY

Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer

(2008) E. Lindholm et al.   BRITISH JOURNAL OF SURGERY

Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

(2008) Bernard Levin et al.   GASTROENTEROLOGY

Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design

(2008) Margaret S. Pepe et al.   JNCI-Journal of the National Cancer Institute